Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
SUMMER INFAN SUMR
6.93%
FEDERAL MOGU FDML
6.24%
NATUS MEDICA BABY
5.55%
NEW ORIENTAL EDU
5.44%

FINRA Cracks Down on Citi over RMBS

by Zacks Equity Research

May 23, 2012 | Comments : 0 Recommended this article: (0)
C BCS DB

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

The Financial Industry Regulatory Authority (FINRA) has cracked down on Citigroup Global Market, a unit of Citigroup Inc. ( C - Analyst Report ) and imposed a fine of $3.5 million for allegedly offering inaccurate information related to subprime residential mortgage-backed securitizations (RMBS). The company was also accused of lacking supervisory procedures as well as violating other norms related to RMBS.

The Allegations

FINRA has accused Citi of providing inaccurate performance data related to three RMBS from January 2006 to October 2007 on its website. In spite of being informed that such information were inaccurate, Citi continued to retain them until early May 2012.

Notably, RMBS issuers need to provide historical performance data for prior securitizations which include mortgage loans that are similar to those in the RMBS they are offering to investors. However, the disclosure of faulty data by Citi likely impacted investors’ assessment as they used such inaccurate data to gauge the value of RMBS.

Moreover, Citi has also been alleged of lacking a proper supervisory procedure for verifying the pricing of these RMBS and failing to document steps for assessing whether trader’s prices were reasonable or not. Citi, also, did not supposedly maintain the required books and records when re-pricing of mortgage backed securities were made following margin calls.

Our Take

Post financial crisis, regulators have intensified their scrutiny in the mortgage market and have come up with charges against the big shots for their fraudulent practices. In fact, besides Citi, other majors who could not escape FINRA’s wrath and were imposed penalties related to similar issues include Barclays Plc. ( BCS - Snapshot Report ) as well as Deutsche Bank AG ( DB - Snapshot Report ) . They have been accused of misinterpreting delinquency data related to RMBS.

Notably, Citi has hit headlines in the past couple of years for issues related to its faulty procedures associated with the mortgage business. The company was subject to a penalty of $75 million in 2010 by the Securities and Exchange Commission for misleading its investors about its exposure to subprime mortgage-related assets. We believe such penalties not only dent the company’s financial but also blemish its reputation.

Citi currently retains its Zacks #3 Rank, which translates to a short-term Hold rating. Considering the fundamentals, we also maintain a long-term Neutral recommendation on the stock.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.